Bloomage BioTechnology Balance Sheet Health
Financial Health criteria checks 6/6
Bloomage BioTechnology has a total shareholder equity of CN¥7.1B and total debt of CN¥127.0M, which brings its debt-to-equity ratio to 1.8%. Its total assets and total liabilities are CN¥8.7B and CN¥1.6B respectively. Bloomage BioTechnology's EBIT is CN¥434.4M making its interest coverage ratio -32.6. It has cash and short-term investments of CN¥541.6M.
Key information
1.8%
Debt to equity ratio
CN¥126.96m
Debt
| Interest coverage ratio | -32.6x |
| Cash | CN¥541.55m |
| Equity | CN¥7.05b |
| Total liabilities | CN¥1.63b |
| Total assets | CN¥8.69b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688363's short term assets (CN¥2.7B) exceed its short term liabilities (CN¥1.1B).
Long Term Liabilities: 688363's short term assets (CN¥2.7B) exceed its long term liabilities (CN¥498.5M).
Debt to Equity History and Analysis
Debt Level: 688363 has more cash than its total debt.
Reducing Debt: 688363's debt to equity ratio has reduced from 1.9% to 1.8% over the past 5 years.
Debt Coverage: 688363's debt is well covered by operating cash flow (581.9%).
Interest Coverage: 688363 earns more interest than it pays, so coverage of interest payments is not a concern.